| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,140,000 | 1,029,000 | 987,000 | 1,063,690 | | Cost of Revenue | (252,000) | (228,000) | 480,000 | (459,615) | | | Gross Profit | 1,392,000 | 1,257,000 | 507,000 | 1,523,305 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 976,000 | 934,000 | 151,000 | 1,077,706 | | Non Recurring | 371,000 |
-
| 22,000 | 38,000 | | Others | 59,000 | 62,000 | 63,000 | 68,815 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 357,000 | 261,000 | 271,000 | 338,784 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 48,000 | 92,000 | (164,000) | (397,360) | | Earnings Before Interest And Taxes | 450,000 | 353,000 | 107,000 | (58,576) | | Interest Expense | 15,000 | 15,000 | 15,000 | 15,165 | | Income Before Tax | 435,000 | 338,000 | 92,000 | (73,741) | | Income Tax Expense | 101,000 | 94,000 | 30,000 | (6,937) | | Minority Interest | (17,000) | (4,000) |
-
| 119,349 | | | | Net Income From Continuing Ops | 317,000 | 240,000 | 62,000 | 52,545 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 317,000 | 240,000 | 62,000 | 52,545 | | Preferred Stock And Other Adjustments |
-
| (22,000) | 22,000 |
-
| | | Net Income Applicable To Common Shares | $317,000 | $218,000 | $84,000 | $52,545 |
|
0.31% Nasdaq 
0.05%
Income Statement
